Cohort of Twin Pregnancy and the Offspring
Launched by FUDAN UNIVERSITY · Feb 13, 2023
Trial Information
Current as of August 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying twin pregnancies to better understand the health risks that mothers and their babies may face. Twin pregnancies can lead to complications like high blood pressure, premature labor, and conditions that affect the growth of the babies. The researchers aim to learn more about the biological differences between twins and how these may impact their health both before and after birth. By gathering information from a group of twin pregnancies and their children, the study hopes to find new treatments and improve care for twin pregnancies.
If you are a woman over 18 years old and are currently expecting twins, you might be eligible to participate in this study. However, if either baby has a serious genetic condition or if there has been a stillbirth, you would not be able to join. Participants in the study will help provide valuable information that could lead to better health outcomes for future mothers and their twins. Your involvement could make a difference in understanding and improving care for twin pregnancies.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. Maternal age \>18 years old.
- • 2. Twin pregnancy.
- Exclusion Criteria:
- • 1. Fetal chromosomal or congenital abnormalities.
- • 2. Stillbirth.
About Fudan University
Fudan University, a prestigious comprehensive research university located in Shanghai, China, is committed to advancing medical science through innovative clinical research. Renowned for its rigorous academic standards and cutting-edge research facilities, Fudan University plays a pivotal role in the global health landscape by sponsoring a diverse array of clinical trials aimed at improving patient outcomes and addressing pressing medical challenges. Leveraging its multidisciplinary expertise and collaborative networks, the university strives to translate scientific discoveries into practical applications, fostering advancements in healthcare and contributing to the well-being of communities both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shanghai, Shanghai, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials